Overview
Status
Active
Registry date
2023-03-29
Share capital
5,000.00 PLN
Registered address
ul. Płk. Leopolda Lisa-Kuli 4, 35-032 Rzeszów, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 3 financial statements was filed late (for 2023, 63 days late).
- 202520/05/2026
- 202413/06/2025
- 202316/09/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 63.33kMedianUSD 91.87kAverageUSD 1.38m
Net profit
This companyUSD 10.85kMedianUSD 2.66kAverageUSD 145.77k
Operating costs
This companyUSD 46.02kMedianUSD 82.72kAverageUSD 1.18m
Assets
This companyUSD 31.58kMedianUSD 39.38kAverageUSD 949.95k
Industry
Authorized Representatives
Paul Ivor Dargan – Management Board Member
David Wood – Management Board Member
Manner of representation
Each member of the management board is authorized to submit declarations and incur obligations on behalf of the company individually without limitations.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Morpheustox Limited | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-07-23.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-09-26 | Hospital emergencies european sentinel monitoring of acute drug-related | $122K$121,989 | DA/JU/EUI - Decentralised Agencies, Joint Undertakings, EU institutions | |
| 2025-09-26 | Emergencies - european sentinel monitoring of acute drug-related harm - phase 1 | $15,912$15,912 | DA/JU/EUI - Decentralised Agencies, Joint Undertakings, EU institutions |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Psychokratessp. z o.o. | $69,656.73 | psychokrates.pl | ||
| CTMsp. z o.o. | $69,435.90 | mutyzm.pl | ||
| Zintegrowanisp. z o.o. | $67,973.02 | zintegrowani.com.pl | ||
| Estetic Eyesp. z o.o. | $66,070.87 | esteticeye.pl | ||
| Centrum Terapii Estisp. z o.o. | $65,494.03 | esti-ct.pl | ||
| Momenty Centrum Psychoterapiisp. z o.o. | $63,992.97 | momentycentrum.pl | ||
| Mapa Motywacjisp. z o.o. | $61,836.12 | mapamotywacji.com.pl | ||
| Dobre Kaloriesp. z o.o. | $57,540.28 | dobrekalorie.com | ||
| Alfahackingsp. z o.o. | $56,994.78 | alfahacking.pl | ||
| Verizensp. z o.o. | $33,374.26 | verizen.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-07-11 | Address change (Al. Gen. Władysława Sikorskiego 42, 35-304, Rzeszów → Ul. Płk. Leopolda Lisa-Kuli 4, 35-032, Rzeszów) | |
| 2023-03-29 | Entered in the register |
FAQ
The main business activity of Morpheustox focuses on other human health activities not elsewhere classified.
The company was registered in the Polish National Court Register (KRS) on March 29, 2023.
The headquarters is located at: ul. Płk. Leopolda Lisa-Kuli 4, 35-032 Rzeszów.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $63,329, representing an increase of 106.2% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $10,855, meaning the company decreased its profit by 24.0%.
The largest operating cost category falls under other operating costs. This category amounted to $38,572 in 2025, representing 84% of all operating expenses.
Last updated: 2026-10-07
